Chimerism Versus Minimal Residual Disease Monitoring After Allogeneic Transplantation—When Do We Act and Will Intervention Improve Outcomes?

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.07.026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Chimerism and Minimal Residual Disease Monitoring After Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction After Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Chimerism Testing and Detection of Minimal Residual Disease After Allogeneic Hematopoietic Transplantation Using the bioView (Duet™) Combined Morphological and Cytogenetical Analysis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Chimerism Monitoring Following Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2007English

Preventing Relapse After Haematopoietic Stem Cell Transplantation for Acute Leukaemia: The Role of Post-Transplantation Minimal Residual Disease (MRD) Monitoring and MRD-directed Intervention

British Journal of Haematology
Hematology
2017English

The Significance of Graft-Versus-Host Disease and Pretransplantation Minimal Residual Disease Status to Outcome After Allogeneic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Minimal Residual Disease Testing After Stem Cell Transplantation for Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2015English

Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring After Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Corrigendum to ‘Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-Versus Host Disease Guided Multiple DLIs Could Improve Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Refractory/Relapsed Acute Leukemia’ [Biology of Blood and Marrow Transplantation 23/8 (2017) 1311-1319]

Biology of Blood and Marrow Transplantation
TransplantationHematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy